1-(3,4,5-Trimethoxycinnamoyl)-4-aminocarbonylethyl-substituted piperazine derivatives and a process for the preparation thereof
申请人:Hokuriku Pharmaceutical Co.,Ltd
公开号:EP0083712A1
公开(公告)日:1983-07-20
1-(3,4,5-Trimethoxycinnamoyl)-4-aminocarbonylethyl-substituted piperazine derivatives represented by general formula (I):
wherein R is a straight- or branched-chain alkyl group having 1 to 6 carbon atoms or a cycloalkyl group having 5 to 7 carbon atoms, and pharmaceutically acceptable acid addition salts thereof are disclosed.
The 1-(3,4,5-trimethoxycinnamoyl)-4-aminocarbonylethyl-substituted piperazine derivatives are useful as vasodilator agents.
1-(3,4,5-三甲氧基肉桂酰基)-4-氨基羰基乙基取代的哌嗪衍生物由通式(I)代表:其中R是具有1至6个碳原子的直链或支链烷基或具有5至7个碳原子的环烷基,以及其药学上可接受的酸加成盐被公开。 1-(3,4,5-三甲氧基肉桂酰基)-4-氨基羰基乙基取代的哌嗪衍生物可用作血管扩张剂。